Search

Reset

Status

Medical Condition

Displaying 1 - 2 of 2

A study for patients with ovarian cancer using biomarker HE-4 to predict recurrence

Condition: Cancer / Gynecologic Cancer
Investigator: Jason Wright, MD
Status: Closed
The purpose of this study is to find out if the study drug, HE4 has the potential to improve performance of biomarker CA 125 to determine recurrence of epithelial ovarian cancer before detecting the cancer clinically, surgically or through radiological scans. HE4 (Human Epididymis Protein 4) is a biomarker expressed in the normal lining of the female…
Read More

Study of CA 125 and HE4 Serum Biomarkers in Women with Ovarian, Fallopian Tube, or Primary Peritoneal Cancers (Excluding Ovarian Tumors)

Condition: Cancer / Gynecologic Cancer
Investigator: Jason Wright, MD
Status: Closed
HE4 (Human Epididymis Protein 4) is a biomarker expressed in the normal lining of the female genital tract and breast. We are doing this research study to if HE4 is an indicator of treatment response during initial therapy for Primary Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancers. For this we will collect…
Read More